40641-71-2

Basic information

• Product Name: 4'-Bromobiphenyl-3-amine
• Synonyms: 4'-Bromobiphenyl-3-amine;4'-Bromo-biphenyl-3-ylamine
• CAS NO: 40641-71-2
• Molecular Formula: C₁₂H₁₀BrN
• Molecular Weight: 248.12
• Mol File: 40641-71-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4'-Bromobiphenyl-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 4'-Bromobiphenyl-3-amine(40641-71-2)
• EPA Substance Registry System: 4'-Bromobiphenyl-3-amine(40641-71-2)

Safety Data

• Hazardous Substances Data: 40641-71-2(Hazardous Substances Data)

Upstream product

• 32858-99-4 4’-bromo-3-nitrobiphenyl 
• 2113-58-8 3-nitro-1,1'-biphenyl 
• 106-37-6 1.4-dibromobenzene 
• 30418-59-8 3-Aminophenylboronic acid 
• 5467-74-3 4-Bromophenylboronic acid 
• 626-01-7 3-Iodoaniline 

Downstream Products

• 872789-97-4 7-(4-bromo-phenyl)-4-hydroxy-quinoline-2-carboxylic acid ethyl ester 
• 130201-21-7 4’-bromo-3-iodo-1,1’-biphenyl 
• 91354-09-5 4-bromo-3'-chloro-1,1'-biphenyl 
• 586-76-5 4-Bromobenzoic acid 
• 874499-34-0 7-(4-bromo-phenyl)-quinolin-4-ol 
• 860719-81-9 7-(4-bromo-phenyl)-4-chloro-quinoline 
• 872789-98-5 7-(4-bromo-phenyl)-4-hydroxy-quinoline-2-carboxylic acid 
• 1202678-15-6 C₂₄H₂₀BrN₃O₃ 
• 130201-29-5 3,3'''-Bis<<1-(biphenyl-3-yl)-2-methyl-1-propenyl>>-p-quaterphenyl 
• 130201-23-9 1,1-Bis(4'-brombiphenyl-3-yl)-2-propyl-1-pentanol 
• 130201-28-4 2,2-Bis(4'-brombiphenyl-3-yl)-1,3-dioxan 
• 130201-25-1 1,1-Bis(4'-brombiphenyl-3-yl)-2-propyl-1-penten 
• 130201-22-8 1,1-Bis(4'-brombiphenyl-3-yl)-2-methyl-1-propanol 
• 130201-26-2 Bis(4'-brombiphenyl-3-yl)methanol 

Relevant articles and documents

ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE

The application is directed to compounds of formulae (IA) and (IB): (IA) and (IB), and their salts and solvates, wherein R1a, R2a, A1, A2, A3, A4, R1b, R2b, B1, B2, B3, and G are as set forth in the specification, as well as to methods for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of, e.g., lysosomal storage diseases, such as Krabbe's disease, and α-synucleinopathies, such as Parkinson's disease.

Covalent Dimers of 1,3-Diphenylisobenzofuran for Singlet Fission: Synthesis and Electrochemistry

Abstract The synthesis of covalent dimers in which two 1,3-diphenylisobenzofuran units are connected through one phenyl substituent on each is reported. In three of the dimers, the subunits are linked directly, and in three others, they are linked via an

LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT

This invention provides compounds of formula (I) or its pharmacologically acceptable salt or solvate, wherein A represents aryl or a monocyclic or bicyclic heterocyclic group, R1 represents a halide, nitro, substituted C1-6 alkyl, optionally substituted amino, C1-6 alkyloxycarbonyl, optionally substituted aryl, a heterocyclic group, or heterocyclic carbonyl, R2 represents a hydrogen atom or C1-6 alkyl, R3 represents C1-6 alkyl, all of R4, R5, and R6 represent a hydrogen atom, R7 represents C1-6 alkyl, m is 1 or 2, and n is 1. The compounds are novel lincomycin derivatives having a potent activity against resistant pneumococci. The compounds can be used as an antimicrobial agent and are useful for preventing or treating bacterial infectious diseases.